新产品
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 185253 | ARV-825 | 1818885-28-7 | >98% |  |
| ARV-825是一种保护蛋白(蛋白酶-靶向嵌合体)。ARV-825与溴域抑制剂(B | ||||
| 188281 | Arimoclomol maleate | 289893-26-1 | 98% |  |
| Arimoclomol，也被称为BRX-220，能够潜在有用的治疗Niemann-Pick疾病C型 | ||||
| 1811162 | PF-05231023 | 1037589-69-7 | >98% |  |
| PF-05231023是一种长效FGF21仿生产品。PF-05231023可以减轻非人类灵长类 | ||||
| 1811211 | Anlotinib HCl ( AL-3818 ) | 1360460-82-7 | ≧98.0% | _1360460-82-7.png) |
| Anlotinib也被称为AL3818，是一种受体酪氨酸激酶(RTK)抑制剂，具有潜 | ||||
| 191122 | Tafenoquine ( 他非诺喹 ) | 106635-80-7 | ≧98.0% |  |
| Tafenoquine is being investigated as a potential treatment for malaria, as well as fo | ||||
| 193282 | PZ-2891 | 2170608-82-7 | ≧98.0% |  |
| PZ-2891是一种强效的、选择性的、口服活性泛酸激酶(PANK)调制剂， | ||||
| 193283 | CT1812 ( Zervimesine ) | 1802632-22-9 | ≧98.0% |  |
| CT-1812是一种同类首创的、可口服的sigma-2/PGRMC1拮抗剂（αβ寡聚体 | ||||
| S510901 | Cenicriviroc Mesylate | 497223-28-6 | 98% Min. |  |
| Cenicriviroc（代号TAK-652，TBR-652）是用于治疗HIV感染的实验候选药物 | ||||
| 512193 | ITI-214磷酸盐 | 1642303-38-5 | 98% Min. |  |
| ITI-214 is a potent and selective phosphodiesterase 1 (PDE1) inhibitor. As the clinic | ||||
| 6111901 | UNC2541 | 1612782-86-1 | 98% Min. |  |
| UNC2541 is a potent and MerTK-specific inhibitor and exhibits sub-micro molar inhibit | ||||
| 112591 | U-73343 | 142878-12-4 | 98% Min. |  |
| U-73343 is a negative control (or inactive analogue) of U73122, which is a putative p | ||||
| 204302 | Lerociclib | 1628256-23-4 (free base) | 98% | .png) |
| Lerociclib，也称为G1T38，是一种口服，有效和选择性的CDK4 / 6抑制剂 | ||||